Rex A. Parker
17Patents
8h-index
30Co-inventors
72Inventor score
Filing activity: Sep 17, 1990 → Feb 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7572618B2 | Polynucleotides encoding novel PCSK9 variants | Emerging Cross-Sectional Technologies | 86 | Active |
| US8420098B2 | Fibronectin based scaffold domain proteins that bind to PCSK9 | Chemistry; Metallurgy | 77 | Active |
| US5348974A | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Chemistry; Metallurgy | 25 | Expired |
| US5217992A | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Chemistry; Metallurgy | 21 | Expired |
| US7846706B2 | PCSK9 polypeptides | Emerging Cross-Sectional Technologies | 19 | Active |
| US8105804B2 | Polynucleotides encoding novel PCSK9 variants | Emerging Cross-Sectional Technologies | 12 | Active |
| US8354264B2 | Polynucleotides encoding novel PCSK9 variants | Emerging Cross-Sectional Technologies | 11 | Active |
| US7358254B2 | Method for treating atherosclerosis employing an aP2 inhibitor and combination | Human Necessities | 11 | Expired |
| US7390824B1 | Method for treating diabetes employing an aP2 inhibitor and combination | Human Necessities | 8 | Expired |
| US9856309B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 7 | Active |
| US9234027B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 6 | Active |
| US10947297B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 3 | Active |
| US10442851B2 | Serum albumin-binding fibronectin type III domains | Chemistry; Metallurgy | 3 | Active |
| US6984645B2 | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein | Chemistry; Metallurgy | 2 | Expired |
| US11858979B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 0 | Active |
| US11203630B2 | Serum albumin-binding fibronectin type III domains | Chemistry; Metallurgy | 0 | Active |
| US5488068A | Aminobiphenyl-4-ol anti-atherosclerotic compounds and method | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.